Showing results (31-40 of 146) with videos related to
Sort By:
Pageof 15
Expert Opinion on Emerging Drugs|November 3, 2005
Emerging drugs for renal cell carcinomaPhilip E Shaheen, Ronald M BukowskiClinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2004
Prognostic factors in patients with advanced renal cell carcinoma: development of an international kidney cancer working groupRonald M Bukowski, Sylvie Negrier, Paul ElsonCurrent Cancer Drug Targets|December 17, 2008
Anti-angiogenic targets in the treatment of advanced renal cell carcinomaDaniel Y C Heng, Ronald M BukowskiCancer|March 11, 2003
Therapy and outcome of small cell carcinoma of the kidney: report of two cases and a systematic review of the literatureNavneet S Majhail, Paul Elson, Ronald M BukowskiReviews on Recent Clinical Trials|March 5, 2010
Stable disease in renal cell carcinoma after using signal transduction inhibitorsSaby George, Shetal N Shah, Ronald M BukowskiClinical Genitourinary Cancer|July 25, 2006
Clinical activity of sorafenib and sunitinib in renal cell carcinoma refractory to previous vascular endothelial growth factor-targeted therapy: two case reportsPhilip E Shaheen, Brian I Rini, Ronald M BukowskiExpert Review of Anticancer Therapy|November 18, 2010
Burden of metastatic bone disease from genitourinary malignanciesPeter F Mulders, Per-Anders Abrahamsson, Ronald M BukowskiCurrent Oncology Reports|April 29, 2010
RANK ligand: effects of inhibitionSaby George, Andrew Brenner, John Sarantopoulos, et al.Expert Review of Anticancer Therapy|December 23, 2003
Evolving role of pegylated interferons in metastatic renal cell carcinomaToni K Choueiri, Thomas E Hutson, Ronald M BukowskiCurrent Oncology Reports|February 17, 2009
Myeloid-derived suppressor cells: a novel therapeutic targetJennifer S Ko, Ronald M Bukowski, James H FinckePageof 15